These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32833560)

  • 1. A Pilot Study Examining the Effects of GLP-1 Receptor Blockade Using Exendin-(9,39) on Gastric Emptying and Caloric Intake in Subjects With and Without Bariatric Surgery.
    Kittah E; Camilleri M; Jensen MD; Vella A
    Metab Syndr Relat Disord; 2020 Nov; 18(9):406-412. PubMed ID: 32833560
    [No Abstract]   [Full Text] [Related]  

  • 2. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial.
    Yang J; Gao Z; Williams DB; Wang C; Lee S; Zhou X; Qiu P
    Surg Obes Relat Dis; 2018 Oct; 14(10):1521-1529. PubMed ID: 30449509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies.
    Hindsø M; Svane MS; Hedbäck N; Holst JJ; Madsbad S; Bojsen-Møller KN
    Surg Obes Relat Dis; 2021 Jul; 17(7):1383-1391. PubMed ID: 33771461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
    Papamargaritis D; le Roux CW
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
    Svane MS; Bojsen-Møller KN; Martinussen C; Dirksen C; Madsen JL; Reitelseder S; Holm L; Rehfeld JF; Kristiansen VB; van Hall G; Holst JJ; Madsbad S
    Gastroenterology; 2019 May; 156(6):1627-1641.e1. PubMed ID: 30742833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss.
    Nielsen MS; Ritz C; Wewer Albrechtsen NJ; Holst JJ; le Roux CW; Sjödin A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32016415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery.
    Roberts GP; Kay RG; Howard J; Hardwick RH; Reimann F; Gribble FM
    Surg Obes Relat Dis; 2018 May; 14(5):562-568. PubMed ID: 29548882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it?
    Smith EP; Polanco G; Yaqub A; Salehi M
    Metabolism; 2018 Jun; 83():159-166. PubMed ID: 29113813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty.
    Svane MS; Øhrstrøm CC; Plamboeck A; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Martinussen C; Vilsbøll T; Hartmann B; Deacon CF; Kristiansen VB; Knop FK; Svendsen LB; Madsbad S; Holst JJ; Veedfald S
    Neurogastroenterol Motil; 2022 Jan; 34(1):e14210. PubMed ID: 34378827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes.
    Rohde U; Federspiel CA; Vilmann P; Langholz E; Friis SU; Krakauer M; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2017 Feb; 19(2):189-199. PubMed ID: 27696668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the Changes in Gastrointestinal Hormone Secretion Necessary for the Success of Bariatric Surgery? A Critical Review of the Literature.
    Lampropoulos C; Alexandrides T; Tsochatzis S; Kehagias D; Kehagias I
    Obes Surg; 2021 Oct; 31(10):4575-4584. PubMed ID: 34304379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy.
    Chambers AP; Smith EP; Begg DP; Grayson BE; Sisley S; Greer T; Sorrell J; Lemmen L; LaSance K; Woods SC; Seeley RJ; D'Alessio DA; Sandoval DA
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E424-32. PubMed ID: 24368666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
    Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
    Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
    Craig CM; Liu LF; Deacon CF; Holst JJ; McLaughlin TL
    Diabetologia; 2017 Mar; 60(3):531-540. PubMed ID: 27975209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia.
    Mulla CM; Goldfine AB; Dreyfuss JM; Houten S; Pan H; Pober DM; Wewer Albrechtsen NJ; Svane MS; Schmidt JB; Holst JJ; Craig CM; McLaughlin TL; Patti ME
    Obes Surg; 2019 Jul; 29(7):2092-2099. PubMed ID: 30976983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates in weight loss surgery and gastrointestinal peptides.
    Svane MS; Bojsen-Møller KN; Madsbad S; Holst JJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):21-8. PubMed ID: 25517025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA
    Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.